Wolverine Asset Management LLC Biomarin Pharmaceutical Inc Put Options Transaction History

Wolverine Asset Management LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2021 May 13, 2021	BUY	$74.73 - $90.69 $597,840 - $725,520	8,000 Added 2000.0%	8,400 $634,000
Q4 2020 Feb 12, 2021	BUY	$72.61 - $90.2 $29,044 - $36,080	400 New	400 $35,000
Q3 2019 Nov 14, 2019	SELL	$67.4 - $85.11 $451,580 - $570,237	-6,700 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $564,140 - $660,754	6,700 New	6,700 $595,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.